SH5008QA Reduce Smoking in High-Risk Populations in the UK

Introduction

The current essay examines the most promising evidence-based population health strategies to prevent smoking among people at risk of smoking in the United Kingdom. Evidence-Based Public Health (EBPH) brings the best research evidence, as well as practitioner experience and stakeholders together to inform interventions that enhance population outcomes (West et al., 2015). Even though smoking levels are generally decreasing, the issue is still disproportionately prevalent among certain groups, including people with severe mental illness, homeless people, and residents of socioeconomically deprived neighbourhoods (Peckham et al., 2017). Preventable disease and death by smoking in the UK persist to be a major cause of morbidity and mortality. This leads to a context in which health disparities still exist and merit specific interventions. Among the interventions that will be discussed in the essay, are pharmacotherapy and behavioural support, individualised outreach plans such as the Start2quit program, and mental health integrated services.

For students exploring public health topics, Native Assignment Help offers academic guidance on structuring assignments, developing critical arguments and understanding evidence-based healthcare strategies. An experienced Assignment Helper UK can help students understand public health concepts, organise research and improve academic writing in line with UK university expectations.

Main Discussion

Key Definitions

In order to discuss critically the efforts that have been made towards reducing smoking among the people at risk, it would be important to mention some concepts that are key in the discussion. The term Evidence-Based Public Health (EBPH) can be defined as the process of using evidence-based scientific research to advance population health results by combining community preferences, professional skills and knowledge, and situational information (West et al., 2015). It will make sure that decisions regarding the health of the populations will be made based on the best available knowledge, and will be adapted to the real-life requirements. Populations at the risk of smoking and associated harms are those at high risk of it because of socioeconomic, psychological, or disease-related reasons(Spanakis et al., 2021). In the case of the UK, they are individuals with severe mental illness, people living in homelessness, those who live in socioeconomically deprived neighbourhoods, and comorbid substance use (Peckham et al., 2017). Smoking cessation interventions are designed plans to assist people to quit smoking.

Contextual background information

In the U.K., although there has been a massive decline in the prevalence of smoking in the past few decades, smoking still constitutes one of the most dominant forms of preventable morbidity and mortality. The Office for National Statistics (2023) reports that the share of adults gritting their teeth in England declined in 2022 (12.9 percent) compared to 2019 (14.1 percent). Although this trend indicates the effectiveness of national tobacco control measures, smoking rates remain excessively high among certain high-risk populations, especially individuals with severe mental illness, persons who are homeless, and those in socioeconomically deprived populations. Such constant inequities make smoking stoppage among high-risk groups one of the most crucial health concerns(ASH, 2022). It is revealed that severely mentally challenged people are at least twofold smokers than ordinary individuals. According to Spanakis et al. (2021), the prevalence of regular smoking among individuals with schizophrenia and bipolar disorder in the UK reaches 57 and 45% respectively. The given population not only has increased smoking but also a greater nicotine dependency and reduction in the quit rate. All these are compounded by socioeconomic factors, inaccessibility of customized cessation services, and myths in mental health services that smoking provides relief(Baker et al., 2020). Causes and consequences in this respect cycle into addiction and negative health outcomes that increase the disparity gap in life expectancy and overall health between this community and the general population. The other population at risk where the smoking rates are extremely high includes people living without a home. According to research provided by Public Health England (2019), more than 77 percent of people in this cohort smoke, most of whom began smoking at an early age and acquired deep-rooted habits that are justified by social norms, stress, and the inability to receive healthcare services. The issue of smoking in this context is frequently accompanied by mental disorders, substance abuse, and lack of stable living conditions, so cessation intervention becomes more complicated and is less available. Moreover, a transient way of life experienced by homeless people is additionally problematic when it comes to getting individuals involved in regular cessation support, follow-up, or access to pharmacotherapy(Department of Health and Social Care, 2022).

Disproportionately affected by tobacco-related harm are socioeconomically deprived populations as well. The Marmot Review (2020) reinforced that one of the causes of the disparity between the poorest and richest communities in the UK when it comes to life expectancy was attributed to smoking. People who have lower incomes and live in families are likely to start smoking at an earlier age, are less likely to quit smoking, and are vulnerable to the marketing tactics of the tobacco industry. Going further, smoking adds to the financial instability caused by the inflated price of tobacco, and it creates a vicious circle of poverty and poor health. The availability of mainstream smoking cessation programs is not limited; however, how they may be reached on a structural level, by the depressed population, is limited, including low health literacy, low access to culturally appropriate treatment, and transportation barriers getting to appointments(Freeman et al., 2020). The UK government has adopted numerous kinds of tobacco control policies to ensure that the smoking prevalence declines and most of these policies conform to the WHO FCTC. The main national policies are the duty on tobacco products, prohibition of advertising and smoking in the workplaces, plain packaging laws, and NHS Stop Smoking Services. The Tobacco Control Plan in England 2017 was ambitious in aiming for a smoke-free generation in 2030, as well as reducing the prevalence of adult smoking to 12% in 2022(Hiscock et al., 2020). Despite few gains, the plan recognized the need to consider the issue of smoking among poor and vulnerable citizens as a way to ensure equity in health outcomes. The framework developed by Public Health England (which is now called the Office of Health Improvement and Disparities) has progressively shifted towards establishing more target-led strategies on how to deal with smoking inequalities. As an illustration, a program with the Start2quit name, which was examined by Wu et al. (2017), offered personalized recruitment tools using invitation letters signed by GPs and free taster classes to drive participation in cessation services. Not only was the given approach proven to be more effective than the most traditional NHS campaigns, but it also proved cost-effective in the long-term perspective and the cost-effective one, especially among low-income groups of smokers. The program proved that friendly initiatives and individual sharings greatly enhanced cessation support availability among poor communities(Marmot and Allen, 2020).

Interventions that are specific to mental health have also become popular over the past years. Peckham et al. (2017) have underlined the necessity to integrate smoking cessation interventions into normal mental healthcare procedures. Combined care involving behavioural counselling, motivational interviewing, and pharmacological interventions like varenicline have revealed positive findings in enhancing the smoking cessation of severely mentally ill people. According to the works (Spanakis et al., 2021), the authors suggest community-based models where trust can be established by relying on peer support, culturally competent care, and clinician training, which encourage an increase in service uptake. Even though there is good evidence, it is not uniform throughout the country in that implementation is limited by fragmented services, stigma, and lack of dedicated funding. In order to enhance further the work towards improving the population's health, the National Institute of Health and Care Excellence (NICE) presents evidence-based pieces of advice as per which every member of the medical community should identify smokers so that they can provide brief assistance and give some information about quitting(NICE, 2021). Broader application of pharmacotherapies, such as nicotine replacement therapy (NRT), bupropion, and varenicline, also is recommended by NICE guidelines, since they have been previously shown effective among various population groups. The principles underscore the use of a graded treatment, such as behavioural therapy either on an individual or group basis and to make sure that the treatment is tailored to fit the unique needs of high-risk populations. As an example, the outreach teams serving the rough sleepers may be required to provide interventions in the shelter, hostel, or in the street(ONS, 2023). On data, data currently available through Local Tobacco Control Profiles published by the Office for Health Improvement and Disparities provides a regional appreciation of the smoking population to quit attempts, success rates, and access to services. Strong geographical disparity is also shown in these data, where urban, industrial, and deprived areas have a higher smoking problem and less cessation success. The given data emphasizes the importance of place-based interventions which would take into account the peculiarities of demographics, cultural situations, and infrastructure issues of various areas(Peckham et al., 2017). There is also another essential aspect in the contextualization of smoking cessation among high-risk populations which is financial considerations. Action on Smoking and Health (ASH) estimates that in the UK, smoking imposes an annual economic burden to society of (summing up costs of healthcare, lost productivity, and social care) about 17 bn GB. The NHS is highly stretched in terms of its resources by smoking-related illness, especially in the mental health services and primary care where the smoking sickness is highly visible. Investments in targeted cessation services are not only beneficial to health outcomes but also deliver considerable economic returns in the form of a decrease in the cost of the burden of disease and the cost of long-term care. Further, a policy opportunity to combine smoking cessation with other social changes can be found in the levelling-up agenda of the UK government that seeks to reduce regional inequalities in health, education, and income(Peckham et al., 2017).

Evidence-Based Solutions to Reduce Smoking in High-Risk Populations in the UK: A Theory-Informed Approach

The involvement of sound evidence and theory in the context of smoking among the high-risk populations in the United Kingdom will assist in improving the number of attempts to reduce smoking in these populations. In the essay plan, the main theoretical foundations are explained, and the primary of them are the Evidence-Based Public Health (EBPH) approach and the Socioecological Model which helps to plan and execute effective interventions. These models lay importance upon the use of research evidence, practitioner experience, stakeholder information, and contextual knowledge to achieve better health outcomes and intervene in structural determinants of health. EBPH model also promotes the creation of both validated and practical interventions(Public Health England, 2019). In the UK, this entails the application of programs to the specific requirements of groups like persons with severe mental disorders, the homeless, and the people living in disadvantaged communities. As an example, one of the most efficient interventions may be to combine pharmacological and behavioural support, which is proved by West et al. (2015). When used in combination with behavioural counselling, pharmacotherapies such as varenicline and nicotine replacement therapy (NRT) are very effective when it comes to cessation. Implemented as EBPH-aligned, accessible, evidence-based pathways to cessation as recommended within the NICE guidelines, Stop Smoking Services of the National Health Service (NHS) operationalizes this approach(Public Health England, 2019). In addition, the Start2quit program, as assessed by Wu et al. (2017), is an example of the utilization of EBPH insofar as targeted proactive recruitment of new clients (smokers) through invitation letters signed by the GPs and free taster sessions, particularly those with a deprived background. The approach produced high uptake and quit rates in comparison with regular national campaigns. It proves that the integration of research-informed practices into the actual practice and making sure that interventions are made to be more personal and affordable is a worthwhile concept. Significantly, the Start2quit method uses the EBPH stress on community and stakeholder engagement, as they individualize the communication so as to confirm that interventions need to be specific to place to succeed. The Socioecological Model works hand in hand with the EBPH since it identifies the various levels of the actions affecting smoking behaviours, including individual beliefs and psychological traits, community norms, and policies. The implementation of this model would guarantee that interventions are not limited to the power of will, but also reach the more systemic issues that encourage smoking among the high-risk population. At a personal level, cognitive-behavioural therapy (CBT) and motivational interviewing assist in the treatment of psychological dependence especially in the mentally ill. Spanakis, et al. (2021) found that integrating such interventions into ordinary care in mental health care enhances the outcomes of smoking cessation as well as psychiatric effects(Tattan-Birch et al., 2021). These results substantiate the need to consider the adoption of integrated care initiatives wherein quitting smoking ceases to be viewed as a specific group of health concerns but rather as an element of overall well-being. On the interpersonal and organizational levels, peer support and training of clinicians can improve the effectiveness and intervention uptake. Clinicians who have been trained in offering smoking cessation advice regarding mental health would be in a better position to offer brief interventions regularly. This also minimizes stigma and the age-old myth that persons with mental illness do not want to quit and are unable to succeed. Interventions can be implemented within a community mental health team, which has been suggested by Peckham et al. (2017), who stated the importance of doing so to ensure that people can obtain necessary support in a familiar setting and feel more engaged and retained. Any community-based intervention should respond to social causes of smoking, including unemployment, tenure insecure habitat, and low income. People in disadvantaged communities usually experience various obstacles such as lack of access to healthcare services, cultural marginalization, and stresses that condone smoking as a coping strategy. The socio-ecological approach requires such structural problems to be addressed as well as cessation tools provision. Given the logistics challenge of marginalized groups, community-based services in easy-to-reach locations, like shelters, food banks, or community centres, can help to address the challenge. The message in public health attention must also be culturally relevant and must be conveyed by people who are trusted members of the community to make them relevant and effective(Taylor et al., 2021). The EBPH model at the policy level advocates the use of data and evidence in driving systemic change. Both the Tobacco Control Plan (2017) and the NHS Long Term Plan put health inequalities at the forefront of their priorities, however, levels of implementation need to be enhanced via a combination of specific funding, evaluation data, and streamlined method of service. By focusing on equity outcomes, which is recommended by Peckham et al. (2017), one can make sure that leaving high-risk populations is not an outcome. In addition, measures that encourage smokers to quit smoking by offering them incentives like prescription reimbursements or reward programs where they get rewarded upon quitting successfully can play an important role in motivating people who are on the lower end of the financial scale(West et al., 2015).

Conclusion

Conclusively, the scope of response to smoking in high-risk individuals of the UK should be comprehensive and evidence-based based on the application of the EBPH framework and Socioecological Model. Pharmacotherapy in combination with behavioural assistance and active recruitment methods is very effective especially when it suits the needs of sub-sensitive populations. To reduce health inequalities, it is necessary to embed cessation support into mental health and community services, as well as into structural interventions to deal with social determinants. Policy changes should lay more emphasis on focused funding, equity tracking, and integration of services. Through these multi-level approaches, the UK can achieve a lot in relation to making society smoke-free and healthier.

References

Action on Smoking and Health (ASH), 2022. The cost of smoking to the social care system. [online] Available at: https://ash.org.uk/resources/view/cost-of-smoking-to-social-care-2022 [Accessed 28 Jun. 2025].

Baker, A.L., McCarter, K., Bonevski, B. and Kay-Lambkin, F.J., 2020. Smoking cessation and mental illness: A bibliometric analysis. Nicotine & Tobacco Research, 22(5), pp.785–794.

Department of Health and Social Care, 2022. Towards a smoke-free generation: A tobacco control plan for England. London: DHSC.

Freeman, B., Jardine, A., Martin, J., McKenzie, L. and Jones, S.C., 2020. Support for tobacco control interventions among social disadvantage groups: A systematic review. Tobacco Induced Diseases, 18(1), p.34.

Hiscock, R., Bauld, L., Amos, A., Fidler, J.A. and Munafò, M., 2020. Socioeconomic status and smoking: a review. Annals of the New York Academy of Sciences, 1248(1), pp.107–123.

Marmot, M. and Allen, J., 2020. Build back fairer: The COVID-19 Marmot review. London: Institute of Health Equity.

NICE, 2021. Stop smoking interventions and services [NG92]. London: National Institute for Health and Care Excellence.

Office for National Statistics (ONS), 2023. Adult smoking habits in the UK: 2022. [online] Available at: https://www.ons.gov.uk [Accessed 28 Jun. 2025].

Peckham, E., Bradshaw, T., Brabyn, S., Baker, J. and Gilbody, S., 2017. Smoking cessation in severe mental ill health: What works? An updated systematic review and meta-analysis. BMC Psychiatry, 17(1), pp.1–10.

Public Health England, 2019. Health matters: smoking and mental health. London: PHE.

Spanakis, P., Peckham, E., Mathers, A., Shiers, D. and Gilbody, S., 2021. The effectiveness of behavioural smoking cessation interventions for people with severe mental illness: A systematic review and meta-analysis. The Lancet Psychiatry, 8(8), pp.701–714.

Tattan-Birch, H., Perski, O., Jackson, S.E., Shahab, L. and West, R., 2021. COVID-19, smoking, vaping and quitting: A representative population survey in England. Addiction, 116(5), pp.1186–1195.

Taylor, G.M.J., Lindson, N., Farley, A., Leinberger-Jabari, A., Sawyer, K. and Aveyard, P., 2021. Effective implementation of smoking cessation guidelines for people with mental illness: A systematic review. BMJ Open, 11(1), p.e042633.

West, R., May, S., West, M., Croghan, E. and McEwen, A., 2015. Performance of English stop smoking services in first 10 years: Analysis of service monitoring data. BMJ, 350, p.h246.

Wu, Q., Szatkowski, L., Britton, J., Parrott, S. and Lewis, S., 2017. Cost-effectiveness of the national Start2quit programme: A randomised controlled trial. The Lancet Respiratory Medicine, 5(10), pp.835–846.